Has Melissa Perez received payments from drug or device companies?

Yes. Drug and device makers reported $6,962 in general payments to Melissa Perez across 354 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Melissa Perez did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Melissa Perez come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Melissa Perez

Medical · Matthews, NCNPI 1780160374

Payments from drug & device makers

$6,962in general payments, 2019–2025

Across 354 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Supernus Pharmaceuticals, Inc.$1K
Otsuka America Pharmaceutical, Inc.$790
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$694
Teva Pharmaceuticals USA, Inc.$493
Takeda Pharmaceuticals U.S.A., Inc.$331
plus $2K from 18 others

What the payments were for

Food & beverage$6,91099%
Education$521%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	75	$1,422
Supernus Pharmaceuticals, Inc.	76	$1,258
Otsuka America Pharmaceutical, Inc.	48	$790
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	28	$694
Teva Pharmaceuticals USA, Inc.	15	$493
Takeda Pharmaceuticals U.S.A., Inc.	25	$331
Alkermes, Inc.	13	$320
Neurocrine Biosciences, Inc.	10	$262
Johnson & Johnson	7	$251
Sunovion Pharmaceuticals Inc.	8	$195
Lundbeck LLC	10	$186
Corium, LLC	8	$180
Axsome Therapeutics, Inc.	7	$141
Ironshore Pharmaceuticals Inc.	4	$73
Avanir Pharmaceuticals, Inc.	3	$56
Idorsia Pharmaceuticals US Inc	2	$45
Indivior Inc.	2	$44
OWP Pharmaceuticals, Inc.	2	$40
Noven Therapeutics, LLC	2	$36
Almatica Pharma LLC	2	$36
Adlon Therapeutics L.p.	2	$35
Neos Therapeutics, LP	2	$32
Eisai Inc.	2	$28
Merck	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,962 in reported general payments places this provider in the 90th percentile of 878 medical providers in North Carolina.

See all medical providers in North Carolina →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Bupropion XlBupropion Hcl	13	$421
Clonazepam	32	$362
Zolpidem Tartrate	15	$213
Lorazepam	12	$101
Trazodone Hcl	11	$55

Paid to pharmacies, not to this prescriber.

Other medical in Matthews

Grace McLaurinHickory$553K
Joel ThompsonCharlotte$269K
Virginia JethroCary$213K
Payal Soni-PatelAsheville$76K
William JarrettElkin$59K
Amanda ZimmermanWinston Salem$48K
David TaylorMorehead City$40K
Katherine CardSalisbury$39K
John RobbinsWinston Salem$26K
Ashley TipperStatesville$23K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →